Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Melanoma 5Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 4Triple Negative Breast Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Solid Tumor, Adult 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Bites and Stings 2Turcot syndrome 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Oligoprogressive 1Multiple Myeloma 1Liver Neoplasms 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1First-line Advanced NSCLC Patients 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Dermatofibrosarcoma 1Colonic Neoplasms 1

Interventions

Dexamethasone 64Cyclophosphamide 35pomalidomide 34Lenalidomide 34Rituximab 31Bortezomib 30venetoclax 28fludarabine 27Gemcitabine 21carfilzomib 20Paclitaxel 19pembrolizumab 17daratumumab 17Cisplatin 16Carboplatin 15Calcium Dobesilate 14Azacitidine 14ibrutinib 12Docetaxel 12Cytarabine 12obinutuzumab 11Nivolumab 11durvalumab 10Injections 10Doxorubicin 10Bevacizumab 10selinexor 9cemiplimab 9blinatumomab 9Cetuximab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Recurrence × Immune Checkpoint Inhibitors × Clear all
NCT06063681 2025-06-08

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

Stingray Therapeutics

Phase 1 Recruiting
25 enrolled

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡